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Incidence and predictors of tissue prolapse after percutaneous coronary
intervention for saphenous vein graft disease: Intravascular ultrasound study
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Background: The aim of this study was to investigate the relationship between
intravascular ultrasound (IVUS) findings and the no-reflow phenomenon and long-term
outcome after percutaneous coronary intervention (PCI) of saphenous vein graft (SVG)
lesions.
Methods: No-reflow was defined as post-PCI TIMI grade 0, 1, or 2 flow.
Results: Of 311 patients who underwent pre- and post-stenting IVUS, no-reflow was
observed in 39 patients (13%). Degenerated SVG (62% vs. 36%, p0.002) was observed
more frequently in the no-reflow group. IVUS-detected intraluminal mass (82% vs. 43%,
p0.001), culprit lesion multiple plaque ruptures (23% vs. 6%, p0.001), and tissue
prolapse (51% vs. 35%, p0.043) were significantly more common in patients with
no-reflow. In the multivariate logistic regression analysis, an intraluminal mass (Odds
ratio [OR]4.84; 95% CI 1.98-10.49, p0.001), culprit lesion multiple plaque ruptures
(OR3.46; 95% CI 1.46-8.41, p0.014), and degenerated SVGs (OR3.17; 95% CI
1.17-6.56, p0.024) were the independent predictors of post-PCI no-reflow. At 5-year
clinical follow-up, the rates of death [14 (36%) vs. 55 (20%), p0.036] and myocardial
infarction [13 (33%) vs. 52 (19%), p0.039] were significantly higher in the no-reflow
group. However, the rate of target vessel revascularization was not different significantly
between two groups [15 (38%) vs. 90 (33%), p0.3].
Conclusions: IVUS-detected intraluminal mass, multiple plaque ruptures, and degener-
ated SVGs are associated with post-PCI no-reflow in SVG lesions. No-reflow was
associated with poor long-term clinical outcomes after PCI for SVG lesions.
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Stent Thrombosis After Intravascular Ultrasound-guided Stent Implantation
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Background: Intravascular ultrasound (IVUS) is used frequently for percutaneous
coronary intervention (PCI) in Japan. However, there is little information about the
incidence of stent thrombosis after IVUS-guided stent implantation.
Methods: Between January 2005 and December 2011, 2,992 lesions in 2,685 patients
underwent IVUS-guided bare metal stent (BMS) (n981) and drug-eluting stent (DES)
implantation (n2,011). The Academic Research Consortium definition of stent throm-
bosis was used.
Results: Definite stent thrombosis was observed in 10 lesions (1.0%) with BMS (early
0.9%, late 0.1%, and very late 0%) and 9 lesions (0.4%) with DES (early 0.2%, late 0%,
and very late 0.2%). Stent thrombosis occurred in 12 (1.6%) and 7 lesions (0.4%) that had
undergone PCI for acute myocardial infarction and other indications, respectively. Stent
underexpansion was observed in 6 (46%) of the 13 lesions with early stent thrombosis. On
the other hand, none of the 6 lesions with late or very late stent thrombosis had stent
underexpansion.
Conclusions: IVUS-guided stent implantation results in a low incidence of stent
thrombosis. Stent underexpansion is a risk factor of early stent thrombosis, but it was not
for late or very late stent thrombosis.
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Background: Little is known about the role of macrophage accumulations (M) on
bare-metal stent (BMS) failure.
Methods: We evaluated 43 consecutive BMS failure lesions in 43 patients (11 acute
coronary syndrome [ACS] and 32 stable myocardial ischemia [SMI], median stent
duration 9.6 [interquartile range 6.9-58.8] months) by optical coherence tomography.
Neointima with Mwas defined as thin bright layer with shadowing (peak intensity180
and attenuation rate 2, when measurements were fitted to an approximate exponential
function).
Results: The mean age was 67.410.0 years, 40 patients (93.0%) were male, and 16
(37.2%) were diabetic. Compared with SMI patients, ACS patients showed higher
incidence of thin-cap fibroatheroma (TCFA)-containing neointima (63.6% versus 6.3%,
p0.0003), lesions with M (72.7% versus 9.4%, p0.0001), neointimal rupture (72.7%
versus 15.6%, p0.001), thrombus (81.8% versus 43.8%, p0.039), and had higher
admission LDL (116.426.6 versus 90.823.9 mg/dl, p0.012) and lower HDL
cholesterol level (39 [range 33-45] versus 47 [40-55] mg/dl, p0.021). Stent failure with
TCFA-containing neointima (n9) expressed higher incidence of M (88.9% versus
8.8%, p0.0001), larger M angle (143 [range 84-262] versus 0 [0-0] °, p0.002), and
longer M longitudinal length (8 [range 5-13] versus 0 [0-0] mm, p0.003) than
non–TCFA-containing neointima (n34). Fibrous cap thickness negatively correlated
with M longitudinal length (r–0.00449, p0.045). Compared with lesions without
neointimal rupture (n30), lesions with neointimal rupture (n13) demonstrated higher
incidence of M (69.2% versus 6.7%, p0.0001). Thrombotic stent failure lesions
(n23) showed more M (39.1% versus 10.0%, p0.039) than non-thrombotic lesions
(n20). Eleven stent failure patients with M presented later than 32 patients without
M: 104.8 (range 58.8-142.4) versus 9.0 (6.6-13.3) months (p0.0004). Using receiver-
operating curve analysis, 16.7 months was the best predictor of the presence of M with
a sensitivity of 100% and a specificity of 84% (area under curve 0.960, p0.0001).
Conclusions: M might be associated with neoatherosclerosis and unstable features of
BMS neointima.
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Background: Recent studies have demonstrated that peri-strut low intensity area (PLIA)
seen on optical coherence tomography (OCT) represents neointimal fibrinogen and/or
extracellular matrix and is associated with neointimal thickening (NIT) after 1st-
generation drug-eluting stents (DES) implantation. However, there are no data regarding
PLIA in new generation DES and its change in serial OCT evaluations.
Methods: A total of 83 patients underwent 9-month OCT after DES implantation (25
sirolimus-eluting stents [SES], 20 paclitaxel-eluting stents [PES], 30 zotarolimus-eluting
stents [ZES], and 8 everolimus-eluting stents [ZES]). PLIA on OCT was defined as a
region around stent struts with homogenous lower intensity than surrounding tissue
without signal attenuation. Inter-stent analysis was performed between PLIA	 and PLIA
– stents, and then intra-stent analysis was performed between PLIA 	 and overall stent
segments. The patients also underwent 2-year OCT evaluations and serial change of NIT
was analyzed.
Results: The incidence of PLIA 	 stents on 9-month OCT was highest in PES and
lowest in SES (90% in PES vs. 28% in SES vs. 60% in ZES vs. 63% in EES, p0.001).
In inter-stent analysis, PLIA	 stents showed higher mean NIT than PLIA – stents (20.11
 9.69 m vs. 10.86  5.46 m, p 0.001). Also in intra-stent analysis, PLIA 	
segments showed higher mean NIT than overall stent segments (25.79  12.22 m vs.
20.11  9.69 m, p  0.013). On serial 2-year OCT, PLIA 	 stents showed smaller
increase of NIT than PLIA – stents in inter-stent analysis (3.46  10.50 m vs. 7.41 
10.07 m, p  0.092). Also in intra-stent analysis, PLIA 	 segments showed smaller
increase of NIT than overall stent segments (1.76  11.63 m vs. 3.46  10.50 m, p
 0.451). All of these findings were regardless of DES type.
Conclusions: Although PLIA was associated with increased NIT regardless of DES type,
it may mean weak potential for further neointimal growth in long-term follow-up.
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Relationship Between Arterial Remodeling, Fibrous Cap Thinning and Lipid
Accumulation: A Serial Integrated Backscatter Intravascular Ultrasound and
Optical Coherence Tomography Study
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Background: A serial intravascular ultrasound (IVUS) and optical coherence tomogra-
phy (OCT) study has shown that positive arterial remodeling was related to thinning of
fibrous cap. Serial changes in tissue components associated with fibrous cap and/or arterial
remodeling is unknown Therefore, the purpose of this study was to evaluate the
relationship between changes in fibrous cap thickness and changes in plaque tissue
components by using optical coherence tomography (OCT) and integrated backscatter
IVUS (IB-IVUS).
Methods: Serial (baseline and 6 months follow-up) IB-IVUS and OCT examinations
were performed on 81 vessels from 56 patients with ischemic heart disease who
underwent percutaneous coronary intervention. 81 fibroatheromas were selected from 48
culprit lesions and 33 non-culprit lesions. Serial changes and relationships between
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